Full Name
Zhou Shufeng
(not current staff)
Variants
Zhou, S.
Zhou, S.F.
Zhu, S.-F.
Zhou, S.-F.
 
Main Affiliation
 
Faculty
 
Email
phazsf@nus.edu.sg
 

Publications

Refined By:
Department:  BIOCHEMISTRY

Results 1-20 of 24 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
12006A comparison study of cerebral protection using Ginkgo biloba extract and Losartan on stroked ratsLoh, K.P. ; Low, L.S. ; Wong, W.H. ; Zhu, Y.Z. ; Zhou, S. ; Huang, S.H. ; Duan, W. ; De, Silva R.; Chou, W.H.
22006A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhizaZhang, J.; Sui, Y.C.; Zhou, S. ; Hong, Y.-H. ; Duan, W. ; Yang, H.-Y. ; Bian, J.-S. ; Huang, M.; Guan, S.; Bi, H.-C.; Pan, Y.; Chen, X.
32005Determination of thalidomide by high performance liquid chromatography: Plasma pharmacokinetic studies in the ratYang, X.; Hu, Z.; Sui, Y.C.; Ho, P.C.; Chan, E. ; Zhou, S. ; Duan, W. ; Boon, C.G.
42005Human multidrug resistance associated protein 4 confers resistance to camptothecinsTian, Q. ; Zhang, J.; Chan, E.; Sui, Y.C.; Boelsterli, U.A. ; Ho, P.C.-L.; Zhou, S. ; Tan, T.M.C.; Duan, W. ; Yang, H. ; Bian, J.-S. ; Zhu, Y.-Z.; Huang, M.; Xiong, W.; Li, X.
52005Human multidrug resistance associated protein 4 confers resistance to camptothecinsTian, Q.; Zhang, J.; Chan, E.; Sui, Y.C.; Boelsterli, U.A. ; Ho, P.C.-L. ; Zhou, S. ; Tan, T.M.C.; Duan, W. ; Yang, H. ; Bian, J.-S. ; Zhu, Y.-Z. ; Huang, M.; Xiong, W.; Li, X.
62005Insights into oxazaphosphorine resistance and possible approaches to its circumventionZhang, J.; Tian, Q.; Chan, S.Y. ; Zhou, S. ; Duan, W. 
72005Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugsZhou, S. ; Chan, S.Y. ; Chan, E.; Goh, B.C. ; Duan, W. ; Huang, M.; McLeod, H.L.
82006Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancerChen, X.; Hu, Z.-P.; Yang, X.-X.; Chan, S.Y. ; Ho, P.C.-L.; Zhou, S.-F. ; Huang, M.; Gao, Y.; Tang, W.; Dai, X.; Ye, J.; Duan, W. ; Yang, H.-Y.; Zhu, Y.-Z. 
92005Novel agents that potentially inhibit irinotecan-induced diarrheaYang, X.; Hu, Z.; Chan, S.Y. ; Chan, E.; Zhou, S. ; Goh, B.C. ; Duan, W. 
102006Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomideYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Ho, P.C.-L. ; Boelsterli, U.A. ; Ng, K.-Y. ; Chan, E.; Chen, Y.-Z. ; Zhou, S.-F. ; Duan, W. ; Bian, J.-S. ; Huang, M.
112006Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomideYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Ho, P.C.-L. ; Boelsterli, U.A. ; Ng, K.-Y. ; Chan, E.; Chen, Y.-Z. ; Zhou, S.-F. ; Duan, W. ; Bian, J.-S. ; Huang, M.
122006Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in ChineseZhong, S.-L.; Huang, M.; Zhou, S.-F. ; Chan, S.Y. ; Chan, E.; Ng, K.-Y. ; Chen, X.; Duan, W. 
132005Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: Application to plasma pharmacokinetic studies in the ratYang, X.; Hu, Z.; Sui, Y.C.; Chan, E. ; Zhou, S. ; Goh, B.C. ; Duan, W. 
142005Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: Application to plasma pharmacokinetic studies in the ratYang, X.; Hu, Z.; Sui, Y.C.; Chan, E.; Zhou, S. ; Goh, B.C. ; Duan, W. 
152006Small interfering RNA-mediated silencing of cytochrome P450 3A4 geneChen, J.; Huang, M.; He, M.; Chen, X.; Yang, X.-X.; Hu, Z.-P.; Chan, E.; Zhou, S.-F. ; Sheu, F.-S. ; Duan, W. 
162006St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosisHu, Z.-P.; Yang, X.-X.; Chan, S.Y. ; Boelsterli, U.A. ; Chan, E.; Ee, P.L.R. ; Koh, H.L. ; Zhou, S.-F. ; Xu, A.-L.; DUAN WEI ; Zhu, Y.-Z. ; Sheu, F.-S. ; Zhang, Q.; Wang, J.-C.; Huang, M.
1713-Oct-2006The last 10 amino acid residues beyond the hydrophobic motif are critical for the catalytic competence and function of protein kinase CαSui, S.Y.; Zhu, Y.; Smith, D.; Verma, C. ; Wee, G.L.; Bee, J.T. ; Qiu, T.L.; Nam, S.C.; Cai, M.; Zhu, Y.-N.; Zhou, S.-F. ; Tan, S.-L.; Duan, W.
1813-Oct-2006The last 10 amino acid residues beyond the hydrophobic motif are critical for the catalytic competence and function of protein kinase CαSui, S.Y.; Zhu, Y.; Smith, D.; Verma, C. ; Wee, G.L.; Bee, J.T. ; Qiu, T.L.; Nam, S.C.; Cai, M.; Zhu, Y.-N.; Zhou, S.-F. ; Tan, S.-L.; Duan, W.
191-Jun-2005The PKCα-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signalsZhu, Y.; Dong, Q.; Tan, B.J. ; Lim, W.G.; Zhou, S. ; Duan, W.
20Sep-2006The very C-terminus of PRK1/PKN is essential for its activation by RhoA and downstream signalingLim, W.G.; Tan, B.J. ; Zhu, Y.; Zhou, S. ; Armstrong, J.S.; Li, Q.T.; Dong, Q.; Chan, E. ; Smith, D.; Verma, C.; Tan, S.-L.; Duan, W.